Pioneering surgical training technology businesses and UpSurgeOn have announced a global strategic partnership.
The move stands to enhance access to high quality surgical training for thousands of surgeons across the globe.
A centrepiece of the partnership is the integration of UpSurgeOn鈥檚 full portfolio of mixed reality surgical simulation technologies into Inovus Medical鈥檚 Totum digital surgery platform.聽
The integration will create a world-first 鈥榙igital synthetic cadaver鈥� for cranial, spine, ENT, and plastic surgery, combining UpSurgeOn鈥檚 life-like anatomical and tissue simulation with the digital capabilities of Totum.
Inovus Medical will also serve as the commercial partner to UpSurgeOn in several key international territories.
鈥淚 have been a huge fan of the UpSurgeOn team and products for many years,鈥� said Dr Elliot Street, CEO of Inovus Medical.聽
鈥淭he quality and realism of their simulators is unmatched, and by integrating UpSurgeOn鈥檚 expertise in cranial, spine, ENT, and plastic surgery simulation with the Totum platform, we are not only enhancing the offering of both companies, but creating a revolutionary digital synthetic cadaver.聽
鈥淭his world-first innovation represents the future of surgical education – immersive, scalable, and accessible on a global scale, and I am excited to see the positive impact this has on the growth of both businesses.鈥�
Dr Federico Nicolosi, CEO of UpSurgeOn, added: 鈥淚novus has revolutionised the disciplines it operates in, and I have been profoundly inspired by the way they鈥檝e achieved this in General Surgery and Gynecology.聽
鈥淎s a neurosurgeon, during my training, I often envied the immense opportunities my colleagues in those fields had, thanks to the genius of the Inovus team and the unparalleled level of their mixed reality technologies.聽
鈥淭hey have created a new paradigm in these disciplines. Joining forces will have an unprecedented global impact, showcasing to the world that the future of healthcare is deeply rooted in advanced surgical simulation – reducing risks for patients and costs for healthcare institutions, MedTech companies, and insurance providers.鈥�
Inovus Medical receives 拢1m as part of LCR Innovation Zone Programme